These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 27708887)
1. Inflammatory myopathies: One-center experience. Işık M; Bilgen Ş; Doğan İ; Kılıç L Eur J Rheumatol; 2014 Sep; 1(3):96-100. PubMed ID: 27708887 [TBL] [Abstract][Full Text] [Related]
2. Inflammatory myopathies--a review of newly diagnosed patients (2004-2008) in the Counties Manukau region. Gupta R; Gow PJ N Z Med J; 2013 Mar; 126(1370):89-95. PubMed ID: 23474516 [TBL] [Abstract][Full Text] [Related]
3. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419 [TBL] [Abstract][Full Text] [Related]
4. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Choy EH; Hoogendijk JE; Lecky B; Winer JB Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905 [TBL] [Abstract][Full Text] [Related]
6. Use of methotrexate in inflammatory myopathies. Fendler C; Braun J Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S164-7. PubMed ID: 21044453 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Cherin P; Herson S; Wechsler B; Piette JC; Bletry O; Coutellier A; Ziza JM; Godeau P Am J Med; 1991 Aug; 91(2):162-8. PubMed ID: 1714235 [TBL] [Abstract][Full Text] [Related]
8. [Dermatomyositis and polymyositis: clinical aspects and treatment]. Hachulla E Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease. Johnson C; Pinal-Fernandez I; Parikh R; Paik J; Albayda J; Mammen AL; Christopher-Stine L; Danoff S Lung; 2016 Oct; 194(5):733-7. PubMed ID: 27166633 [TBL] [Abstract][Full Text] [Related]
10. Intravenous cyclophosphamide therapy for progressive interstitial pneumonia in patients with polymyositis/dermatomyositis. Yamasaki Y; Yamada H; Yamasaki M; Ohkubo M; Azuma K; Matsuoka S; Kurihara Y; Osada H; Satoh M; Ozaki S Rheumatology (Oxford); 2007 Jan; 46(1):124-30. PubMed ID: 16754626 [TBL] [Abstract][Full Text] [Related]
11. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of steroid-resistant polymyositis and dermatomyositis]. Mimura T; Kanda H; Kubo K Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154 [TBL] [Abstract][Full Text] [Related]
13. Clinical spectrum of inflammatory myositis in South India--a ten year study. Porkodi R; Shanmuganandan K; Parthiban M; Madhavan R; Rajendran P J Assoc Physicians India; 2002 Oct; 50():1255-8. PubMed ID: 12568209 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)]. Tournadre A Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868 [TBL] [Abstract][Full Text] [Related]
15. Idiopathic inflammatory myopathies. van der Kooi AJ; de Visser M Handb Clin Neurol; 2014; 119():495-512. PubMed ID: 24365315 [TBL] [Abstract][Full Text] [Related]
16. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study. Ikeda S; Arita M; Misaki K; Mishima S; Takaiwa T; Nishiyama A; Ito A; Furuta K; Yokoyama T; Tokioka F; Noyama M; Yoshioka H; Ishida T Springerplus; 2015; 4():240. PubMed ID: 26101728 [TBL] [Abstract][Full Text] [Related]
17. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. Kameda H; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Tokuhira M; Amano K; Takeuchi T J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and limitations of pulse cyclophosphamide therapy in polymyositis and dermatomyositis. Nagappa M; Taly AB; Sinha S; Gayathri N; Bindu PS; Mahadevan A; Yasha T J Clin Neuromuscul Dis; 2013 Jun; 14(4):161-8. PubMed ID: 23703010 [TBL] [Abstract][Full Text] [Related]
19. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. Yamasaki Y; Yamada H; Ohkubo M; Yamasaki M; Azuma K; Ogawa H; Mizushima M; Ozaki S J Rheumatol; 2011 Aug; 38(8):1636-43. PubMed ID: 21572147 [TBL] [Abstract][Full Text] [Related]
20. Inclusion body myositis: clinical and pathological boundaries. Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]